Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers

Authors:

Abstract
Over the past several decades, the prevalence of type 2 diabetes (T2D) has increased in the US and globally.1-4 Approximately 1 in 10 people in the US were living with T2D from 2013 to 2016,1,5 and youth-onset T2D has increased in the US by approximately 5% annually from 2002 to 2015.5-7 There are several known risk factors for T2D, including lifestyle, environmental, and psychosocial factors that are key focus areas for prevention.8 Patients and clinicians would also benefit from guidance on choosing between similarly effective medications that may have different metabolic adverse effects.

This publication has 51 references indexed in Scilit: